The FDA approved) administration of a booster to certain groups for the Pfizer Covid vaccine. It is an emergency use authorization for individuals 65 years old and older, people at risk occupationally or due to institutionalization and people with certain high risk conditions). It is given at least 6 months after completing the initial two-shot series.
